Trial intelligence / Profile preview

Minimum effective dose of hypobaric unilateral intrathecal ropivacaine for femoral neck fracture surgery in elderly patients

2008-007205-36Phase 4Active

Sponsor
Hospices Civils de Lyon
Start
Mar 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of ropivacaine in Neck Of Femur Fracture (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Anesthetic technique efficacy. Started Mar 2009; status: active.

02

Drugs

ropivacaine
03

Conditions

Neck Of Femur Fracture

Beyond the preview

Go deeper on 2008-007205-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-007205-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call